Biogen (BIIB) News Today $211.17 -16.27 (-7.15%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 6:15 PM | bizjournals.comEU regulator rejects Biogen, Eisai’s Alzheimer's drugJuly 26 at 6:15 PM | markets.businessinsider.comBuy Rating on Biogen: Anticipating Positive Reversal and Global Market Strength for LecanemabJuly 26 at 6:15 PM | marketwatch.comBiogen Inc. stock underperforms Friday when compared to competitorsJuly 26 at 4:35 PM | marketbeat.comBiogen (NASDAQ:BIIB) Stock Rating Reaffirmed by Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $294.00 target price on shares of Biogen in a research report on Friday.July 26 at 12:00 PM | marketbeat.comBiogen (NASDAQ:BIIB) Shares Gap Down to $227.44Biogen (NASDAQ:BIIB) Shares Gap Down to $227.44July 26 at 9:48 AM | marketbeat.comEuropean committee says Alzheimer's treatment Leqembi shouldn't get marketing approvalShares of Biogen slid Friday after a European regulatory committee said the Alzheimer’s treatment Leqembi should not receive marketing approvalJuly 26 at 8:42 AM | cnbc.comEuropean drug regulator rejects Alzheimer's treatment Leqembi from Biogen, EisaiJuly 26 at 7:59 AM | marketbeat.comCANADA LIFE ASSURANCE Co Sells 20,416 Shares of Biogen Inc. (NASDAQ:BIIB)CANADA LIFE ASSURANCE Co trimmed its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 14.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 125,227 shares of the biotechnology company's stock after sellinJuly 26 at 6:49 AM | reuters.comEU medicines regulator rejects Eisai-Biogen Alzheimer's drugJuly 25 at 9:00 PM | globenewswire.comBIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJuly 25 at 4:51 AM | marketwatch.comBiogen Inc. stock underperforms Wednesday when compared to competitors despite daily gainsJuly 25 at 1:14 AM | americanbankingnews.comBiogen (BIIB) Set to Announce Earnings on ThursdayJuly 24 at 10:36 AM | msn.comSage Therapeutics’ stock dives as failed trial hits Biogen collaborationJuly 24 at 10:36 AM | msn.comIs Biogen (BIIB) an Underappreciated Stock?July 24 at 6:46 AM | reuters.comBiogen and Sage to scrap neurological disorder drug development after trial failureJuly 24 at 12:31 AM | marketwatch.comBiogen Inc. stock rises Monday, still underperforms marketJuly 24 at 12:31 AM | markets.businessinsider.comPiper Sandler Reaffirms Their Buy Rating on Biogen (BIIB)July 22, 2024 | markets.businessinsider.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BiogenJuly 22, 2024 | marketbeat.comVanguard Group Inc. Raises Holdings in Biogen Inc. (NASDAQ:BIIB)Vanguard Group Inc. increased its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 15.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,570,398 shares of the biotechnologJuly 22, 2024 | globenewswire.comLost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery – Contact The Gross Law FirmJuly 22, 2024 | prnewswire.comBiogen Inc. Sued for Securities Law Violations - Contact the Schall Law Firm to Discuss Your Legal Rights BIIBJuly 22, 2024 | businesswire.comBIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law FirmJuly 22, 2024 | prnewswire.comLevi & Korsinsky Reminds Biogen Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2024 - BIIBJuly 22, 2024 | finance.yahoo.comSage Therapeutics/Biogen’s episodic therapy zuranolone could change MDD treatmentJuly 21, 2024 | marketbeat.comIntech Investment Management LLC Cuts Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Intech Investment Management LLC reduced its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 61.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,617 shares of the biotechnoJuly 21, 2024 | markets.businessinsider.comFaruqi & Faruqi, LLP Reminds Shareholders of a Lead Plaintiff Deadline on July 22, 2024 in Biogen LawsuitJuly 20, 2024 | marketbeat.comM&G Plc Buys Shares of 8,593 Biogen Inc. (NASDAQ:BIIB)M&G Plc bought a new stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 8,593 shares of the biotechnology company's stock, valued at approximately $1,856,000. Other institutional invJuly 20, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Novartis AG (Six Swiss: CH:NOVN), Biogen (BIIB) and Sartorius (GB:0NIR)July 20, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines – BIIBJuly 19, 2024 | markets.businessinsider.comHold Rating on Biogen Amid Uncertain Sales Projections for Leqembi and SkyclarysJuly 19, 2024 | tmcnet.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)July 19, 2024 | marketwatch.comBiogen Inc. stock outperforms competitors on strong trading dayJuly 19, 2024 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Acquires 29,991 Shares of Biogen Inc. (NASDAQ:BIIB)Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 20.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 179,419 shares of the biotechnology companyJuly 19, 2024 | prnewswire.comFaruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on July 22, 2024 in Biogen LawsuitJuly 19, 2024 | globenewswire.comMONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - BIIBJuly 19, 2024 | americanbankingnews.comFY2025 EPS Estimates for Biogen Inc. Raised by William Blair (NASDAQ:BIIB)July 18, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIBJuly 18, 2024 | marketbeat.comBiogen Inc. Expected to Earn FY2025 Earnings of $17.36 Per Share (NASDAQ:BIIB)Biogen Inc. (NASDAQ:BIIB - Free Report) - Research analysts at William Blair boosted their FY2025 earnings estimates for shares of Biogen in a report released on Tuesday, July 16th. William Blair analyst M. Minter now anticipates that the biotechnology company will post earnings of $17.36 per shaJuly 18, 2024 | marketbeat.comUS Bancorp DE Has $3.79 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)US Bancorp DE lowered its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 13.1% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,576 shares of the biotechnology company's stock after selling 2,648 shares durJuly 18, 2024 | prnewswire.comLevi & Korsinsky Notifies Shareholders of Biogen Inc.(BIIB) of a Class Action Lawsuit and an Upcoming DeadlineJuly 18, 2024 | globenewswire.comBIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!July 18, 2024 | marketbeat.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $123.02 Million Holdings in Biogen Inc. (NASDAQ:BIIB)BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 27.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 570,533 shares of the biotechnology company's stockJuly 17, 2024 | globenewswire.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)July 17, 2024 | prnewswire.comBiogen Inc. Sued for Securities Law Violations - Contact the Schall Law Firm to Discuss Your Legal Rights BIIBJuly 17, 2024 | americanbankingnews.comBiogen Inc. (NASDAQ:BIIB) to Post Q2 2024 Earnings of $3.97 Per Share, William Blair ForecastsJuly 17, 2024 | prnewswire.comThe Gross Law Firm Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BIIBJuly 16, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Bought by Russell Investments Group Ltd.Russell Investments Group Ltd. increased its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 18.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 146,628 shares of the biotechnologyJuly 16, 2024 | globenewswire.comInvestors in Biogen Inc. Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights – BIIBJuly 16, 2024 | globenewswire.comBIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law FirmJuly 16, 2024 | globenewswire.comINVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - BIIB Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Prepare for a Recession Unlike Any Other (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW. GET THE FREE GUIDE BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.130.62▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3118▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Teva Pharmaceutical Industries News Today American Electric Power News Today Pinnacle West Capital News Today Portland General Electric News Today CRISPR Therapeutics News Today Denali Therapeutics News Today Vertex Pharmaceuticals News Today Regeneron Pharmaceuticals News Today Gilead Sciences News Today Alnylam Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
